Stockscreener 앱 받기
26.85
3.69%
-1.03
시장 영업 전:
26.80
-0.05
-0.19%
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
Crinetics stock price target lowered to $86 by Citizens JMP on launch outlook - Investing.com Canada
Crinetics Pharmaceuticals Inc's Q2 2025 Earnings Call Highlights: Strategic Advancements, Financial Resilience Amid Rising Costs. - AInvest
Crinetics Pharmaceuticals' Q2 2025 Earnings: Financial Vulnerability and Clinical Dependencies Amid Pipeline Advancements - AInvest
Investors Might Be Losing Patience for Crinetics Pharmaceuticals' (NASDAQ:CRNX) Increasing Losses, as Stock Sheds 3.6% Over the Past Week - 富途牛牛
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q2 Loss, Lags Revenue Estimates - MSN
Crinetics Pharmaceuticals: A Pipeline-Driven Inflection Point in Endocrine Therapeutics - AInvest
Crinetics 2025 Q2 Earnings Widening Losses Despite Revenue Surge - AInvest
How to read the order book for Crinetics Pharmaceuticals Inc.Free AI Trading Suggestions With Accuracy Focus - Newser
Transcript : Crinetics Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Crinetics Pharmaceuticals (NASDAQ:CRNX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Stifel lowers Crinetics stock price target to $58 from $60, keeps Buy rating - Investing.com Canada
Earnings call transcript: Crinetics Pharmaceuticals Q2 2025 results miss EPS forecast - Investing.com
Crinetics Pharmaceuticals Inc. (CRNX) Shares Soar 11.91% on 150% Revenue Surge - AInvest
Crinetics Pharmaceuticals Q2 Earnings: Revenue Rises, Shares Up - AInvest
Crinetics Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares up Pre-Bell - MarketScreener
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highlights: Strategic Advancements ... By GuruFocus - Investing.com Canada
Crinetics Pharmaceuticals Inc (CRNX) Q2 2025 Earnings Call Highl - GuruFocus
Will breakout in Crinetics Pharmaceuticals Inc. lead to full recoveryRisk Adjusted Trade Signal Screening Tool - Newser
Decoding Crinetics Pharmaceuticals Inc (CRNX): A Strategic SWOT Insight - GuruFocus
Crinetics Pharmaceuticals: Promising Outlook with Anticipated Approval of Palsonify and Strategic Market Launch - TipRanks
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Crinetics reports Q2 EPS ($1.23), consensus ($1.10) - TipRanks
Why Crinetics Pharmaceuticals Inc. stock attracts strong analyst attentionSmart Risk Entry Zone Technical Analysis - Newser
Crinetics Pharma earnings missed by $0.13, revenue topped estimates - Investing.com Canada
Crinetics Q2: $1.2B cash, PDUFA date for PALSONIFY, atumelnant progress. - AInvest
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | CRNX Stock News - GuruFocus
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Crinetics Earnings: $1.2B War Chest Powers PALSONIFY Launch, FDA Decision Looms in September - Stock Titan
Crinetics Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Crinetics CRNX Q2 2025 Earnings Preview Downside Expected on Analyst EPS Downgrades - AInvest
Crinetics Pharmaceuticals, Inc. (CRNX)’ Oral Acromegaly Drug Nears FDA Decision After Strong Phase 3 Data - MSN
What are the technical indicators suggesting about Crinetics Pharmaceuticals Inc.Dynamic investment growth - Jammu Links News
Is it the right time to buy Crinetics Pharmaceuticals Inc. stockFastest-growing stock picks - Jammu Links News
What are analysts’ price targets for Crinetics Pharmaceuticals Inc. in the next 12 monthsStay informed with daily expert analysis - Jammu Links News
What institutional investors are buying Crinetics Pharmaceuticals Inc. stockFree Stock Movement Tracking - Jammu Links News
What is the risk reward ratio of investing in Crinetics Pharmaceuticals Inc. stockOver 200% growth - Jammu Links News
How strong is Crinetics Pharmaceuticals Inc. company’s balance sheetGet timely market insights for better trades - Jammu Links News
Real time alert setup for Crinetics Pharmaceuticals Inc. performanceConsistent Gain Plan with AI Support - Newser
When is Crinetics Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with daily trading signals - Jammu Links News
Does Crinetics Pharmaceuticals Inc. stock perform well during market downturnsGet daily updates on market movers and shakers - Jammu Links News
Fibonacci Support Holding Strong in Crinetics Pharmaceuticals Inc.Trade Timing Strategy With Technical Data Explained - metal.it
Are Bears Losing Grip on Crinetics Pharmaceuticals Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Earnings Preview: Crinetics Pharmaceuticals, Inc. (CRNX) Q2 Earnings Expected to Decline - Yahoo Finance
11 Best Future Stocks to Buy Now - Insider Monkey
What makes Crinetics Pharmaceuticals Inc. stock price move sharplyCapital Preserving Trade Plan Templates Shared - metal.it
Can Crinetics Pharmaceuticals Inc. Bounce Back From Weekly LowSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Analyzing net buyer seller activity in Crinetics Pharmaceuticals Inc.Steady Return Plan Based on Data Analysis - Newser
Using data filters to optimize entry into Crinetics Pharmaceuticals Inc.Technical Screener for High Growth Stocks - Newser
Pattern recognition hints at Crinetics Pharmaceuticals Inc. upsideConsistent Return Setup with Exit Strategy - Newser
How does Crinetics Pharmaceuticals Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Should I hold or sell Crinetics Pharmaceuticals Inc. stock in 2025Best Dividend Updates For Beginners - jammulinksnews.com
0.24%
3.39%
자본화:
|
볼륨(24시간):